<DOC>
	<DOCNO>NCT00810069</DOCNO>
	<brief_summary>This study investigate two different approach change antidepressant treatment initial treatment effective : early intervention delay intervention . Two hypothesis test : 1. time confirm response shorter early intervention strategy vs. delay intervention strategy 2. time confirm remission shorter early intervention strategy compare delay intervention strategy .</brief_summary>
	<brief_title>Early Versus Delayed Switch Medication Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Inclusion Criteria 1 . Male female participant least 18 year age meet criterion Major Depressive Disorder ( MDD ) , single recurrent episode accord Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIV®TR ) disease diagnostic criterion . 2 . Participants ( receive antidepressant treatment ) , base investigator criterion , initiate treatment escitalopram change current Alzheimer 's Disease ( AD ) treatment escitalopram current MDD episode , initial visit . 3 . Must baseline score ≥ 19 17item Hamilton Depression Rating Scale ( HAMD17 ) initial visit . 4 . Must baseline score ≥ 4 Clinical Global ImpressionSeverity Scale ( CGIS ) initial visit . 5 . Have level understanding sufficient provide Informed Consent Document ( ICD ) , communicate investigator site personnel . 6 . Are judge reliable agree keep appointment clinic visit procedure require protocol . 7 . Have current primary Axis I disorder MDD , include limited dysthymia . 8 . Have diagnosis dementia , Alzheimer 's disease ( AD ) , organic brain syndrome ; cognitively impaired language problem prevent understand and/or provide valid answer rating scale content . 9 . Concomitant participation study investigational market product . 10 . Are expect able monitor throughout entire study period reason unrelated illness ( instance , change residence healthcare center reference ) . 11 . Are demonstrate response demonstrate response AD treatment current depression episode previous baseline visit . 12 . Are investigator site personnel directly affiliate study and/or immediate family . `` Immediate family '' define spouse , parent , child , sibling , whether biological legally adopt . 13 . Are employ Lilly Boehringer Ingelheim ( BI ) ( , employee , temporary contract worker , designees responsible conduct study ) . Immediate family Lilly BI employee may participate Lilly BIsponsored clinical trial , permit participate Lilly BI facility . `` Immediate family '' define spouse , parent , child , sibling , whether biological legally adopt . 14 . Women childbearing potential use medically accept mean contraception ( example , intrauterine device , oral contraceptive , contraceptive patch , implant , DepoProvera [ medroxyprogesterone acetate injectable suspension , Pharmacia &amp; Upjohn ] , barrier device ) engage sexual intercourse . Women pregnant breastfeeding may participate study . 15 . Have receive treatment within last 30 day drug receive regulatory approval indication time study entry . 16 . Are judge serious suicidal risk opinion investigator , and/or participant 's baseline ( Visit 1 ) HAMD17 score item 3 suicide 3 . 17 . Have treat monoamine oxidase inhibitor ( MAOI ) within 14 day prior Visit 1 potential need use MAOI study within 5 day discontinuation study drug . 18 . Require initiation discontinuation psychotherapy within 6 week prior enrollment ( Visit 1 ) time study . 19 . Have contraindication use duloxetine base Duloxetine Summary Product Characteristics ( SPC ) contraindication use escitalopram base Escitalopram SPC . 20 . Have history lack response duloxetine escitalopram clinically appropriate dose minimum 4 week , previously complete withdrawn study study investigate duloxetine escitalopram . 21 . Have previous diagnosis bipolar disorder , schizophrenia , psychotic disorder . 22 . Have DSMIVdefined history substance abuse dependence within past year , exclude nicotine caffeine . 23 . Have serious unstable cardiovascular , hepatic , renal , respiratory hematological illness ; symptomatic peripheral vascular disease ; medical ( include unstable hypertension clinically euthyroid ) psychological condition , opinion investigator , would compromise participation likely require hospitalization course study . 24 . Have Electroconvulsive Therapy ( ECT ) Transcranial Magnetic Stimulation within past year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>MDD</keyword>
	<keyword>Depression</keyword>
</DOC>